Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Colonic Diseases

1-methyl-3-isobutylxanthine has been researched along with Colonic Diseases in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Colonic Diseases: Pathological processes in the COLON region of the large intestine (INTESTINE, LARGE).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pérez-Navarro, R1
Martínez-Augustin, O1
Ballester, I1
Zarzuelo, A1
Sánchez de Medina, F1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Colonic Diseases

ArticleYear
Experimental inflammation of the rat distal colon inhibits ion secretion in the proximal colon by affecting the enteric nervous system.
    Naunyn-Schmiedeberg's archives of pharmacology, 2005, Volume: 371, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Carbachol; Cholinergic Agonists; Colon; Colonic Diseases; Fema

2005